Absorption, metabolism, and excretion of [ (14)C]dersimelagon, an investigational oral selective melanocortin 1 receptor agonist, in preclinical species and healthy volunteers

Dersimelagon (formerly MT‐7117) is a novel, orally administered nonpeptide small molecule selective agonist for melanocortin 1 receptor currently being investigated for the treatment of erythropoietic protoporphyria, X‐linked protoporphyria, and diffuse cutaneous systemic sclerosis (dcSSc). Findings...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuda, Minoru, Ogawa, Kei, Endou, Tadashi, Goto, Takahiro, Ogasawara, Yuko, Ogasawara, Akihito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116397/
https://www.ncbi.nlm.nih.gov/pubmed/37078227
http://dx.doi.org/10.1002/prp2.1084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116397/
https://www.ncbi.nlm.nih.gov/pubmed/37078227
http://dx.doi.org/10.1002/prp2.1084

Ejemplares similares